The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis

Stephenson, KE; Porte, J; Kelly, A; Wallace, WA; Huntington, CE; Overed-Sayer, CL; Cohen, ES; Jenkins, RG; John, AE

Stephenson, KE (通讯作者),Univ Nottingham, Sch Med, Div Resp Med, Nottingham, England.;Stephenson, KE (通讯作者),BioPharmaceut R&D, Biosci Asthma & Skin Immun, Res & Early Dev, Resp & Immunol, Cambridge, England.

RESPIRATORY RESEARCH, 2023; 24 (1):

Abstract

BackgroundIdiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease (ILD) with limited treatment options. Interleukin-33 (IL-33) ......

Full Text Link